https://www.selleckchem.com/pr....oducts/Pitavastatin-
However, PORT use was not associated with an increase in the hazard for cardiac-related mortality (subdistribution hazard ratio [SHR] = 0.99, 95% confidence interval [CI] 0.78-1.24, p = 0.91). When evaluating cardiac-related mortality in each time period, the overall incidence of cardiac-related mortality was decreased over time. There were no statistically significant differences based on PORT use in all time periods. With a median follow-up of 25 months, no significant differences were found in cardiac-related mor
Like
Comment
Share
